These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1363807)
21. [Advances in systemic lupus erythematosus]. Kubota T Nihon Rinsho; 1999 Feb; 57(2):329-32. PubMed ID: 10077999 [TBL] [Abstract][Full Text] [Related]
22. Abstracts of the 9th European Lupus Meeting, April 23–26 2014, Athens, Greece. Lupus; 2014; 23(5):449-99. PubMed ID: 24682620 [No Abstract] [Full Text] [Related]
23. Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus. Vincent FB; Northcott M; Hoi A; Mackay F; Morand EF Lupus; 2013 Aug; 22(9):873-84. PubMed ID: 23846230 [TBL] [Abstract][Full Text] [Related]
24. Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review. Alves SC; Fasano S; Isenberg DA Lupus; 2016 Dec; 25(14):1509-1519. PubMed ID: 27329649 [TBL] [Abstract][Full Text] [Related]
25. Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort. Inês L; Silva C; Galindo M; López-Longo FJ; Terroso G; Romão VC; Rúa-Figueroa I; Santos MJ; Pego-Reigosa JM; Nero P; Cerqueira M; Duarte C; Miranda LC; Bernardes M; Gonçalves MJ; Mouriño-Rodriguez C; Araújo F; Raposo A; Barcelos A; Couto M; Abreu P; Otón-Sanchez T; Macieira C; Ramos F; Branco JC; Silva JA; Canhão H; Calvo-Alén J; ; Arthritis Care Res (Hoboken); 2015 Aug; 67(8):1180-5. PubMed ID: 25581417 [TBL] [Abstract][Full Text] [Related]
26. Update on the treatment of systemic lupus erythematosus: therapeutic highlights from the Sixth International Lupus Conference. Abu-Shakra M; Buskila D Isr Med Assoc J; 2002 Jan; 4(1):71-3. PubMed ID: 11802320 [TBL] [Abstract][Full Text] [Related]
27. Risk factors for neuropsychiatric manifestations in children with systemic lupus erythematosus: case-control study. Zuniga Zambrano YC; Guevara Ramos JD; Penagos Vargas NE; Benitez Ramirez DC; Ramirez Rodriguez SM; Vargas Niño AC; Izquierdo Bello AH Pediatr Neurol; 2014 Sep; 51(3):403-9. PubMed ID: 25160546 [TBL] [Abstract][Full Text] [Related]
28. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus. Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054 [TBL] [Abstract][Full Text] [Related]
29. Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study. Checa A; Idborg H; Zandian A; Sar DG; Surowiec I; Trygg J; Svenungsson E; Jakobsson PJ; Nilsson P; Gunnarsson I; Wheelock CE Lupus; 2017 Sep; 26(10):1023-1033. PubMed ID: 28134039 [TBL] [Abstract][Full Text] [Related]
30. Gender disparity in systemic lupus erythematosus, thoughts after the 8th International Congress on Systemic Lupus Erythematosus, Shanghai, China, 2007. Lahita RG J Clin Rheumatol; 2008 Jun; 14(3):185-7. PubMed ID: 18525443 [No Abstract] [Full Text] [Related]
31. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus. Sato JO; Corrente JE; Saad-Magalhães C Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556 [TBL] [Abstract][Full Text] [Related]
32. Low prevalence of Pneumocystis pneumonia in hospitalized patients with systemic lupus erythematosus: review of a clinical data warehouse. Kapoor TM; Mahadeshwar P; Nguyen S; Li J; Kapoor S; Bathon J; Giles J; Askanase A Lupus; 2017 Dec; 26(14):1473-1482. PubMed ID: 28399687 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and factors associated with headache in patients with systemic lupus erythematosus. Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417 [TBL] [Abstract][Full Text] [Related]
34. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis. Maloney KC; Ferguson TS; Stewart HD; Myers AA; De Ceulaer K Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787 [TBL] [Abstract][Full Text] [Related]
35. The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus. Flynn A; Gilhooley E; O'Shea F; Wynne B Clin Rheumatol; 2018 Mar; 37(3):817-818. PubMed ID: 29392510 [TBL] [Abstract][Full Text] [Related]
36. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI). Lattanzi B; Consolaro A; Solari N; Ruperto N; Martini A; Ravelli A Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S112-7. PubMed ID: 22588739 [No Abstract] [Full Text] [Related]